Atea Pharmaceuticals (AVIR) Operating Leases (2022)
Atea Pharmaceuticals has reported Operating Leases over the past 1 years, most recently at $2.6 million for Q3 2022.
Atea Pharmaceuticals has reported Operating Leases over the past 1 years, most recently at $2.6 million for Q3 2022.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month